Nature's Sunshine Products Inc (NATR) FinancialsNATRNature's Sunshine Products Inc

Nature's Sunshine Products Inc (NATR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is General health, accounting for 39.9% of total sales, equivalent to $49.07M. Other significant revenue streams include Digestive and Cardiovascular. Understanding this composition is critical for investors evaluating how NATR navigates market cycles within the Food Processing industry.

Evaluating the bottom line, Nature's Sunshine Products Inc maintains a gross margin of 73.66%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.69%, while the net margin is 3.02%. These profitability ratios, combined with a Return on Equity (ROE) of 11.07%, provide a clear picture of how effectively NATR converts its operational activities into shareholder value.

In the context of the broader market, NATR competes directly with industry leaders such as USNA and NAGE. With a market capitalization of $266.04M, it holds a leading position in the sector. When comparing efficiency, NATR's gross margin of 73.66% stands against USNA's 78.35% and NAGE's 64.84%. Such benchmarking helps identify whether Nature's Sunshine Products Inc is trading at a premium or discount relative to its financial performance.

Nature's Sunshine reported a gross margin of 73.66% in Q2 2026, indicating strong profitability, but the revenue missed expectations by $6.72 million, reflecting weak market demand.